Scientists Create Dust Mite Allergy Vaccine

Thursday, 24 Jul 2014 12:30 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

A research team at the University of Iowa has created a vaccine whose key ingredient, normally used in cancer vaccines, could be effective in provoking natural immune responses that combat dust mite allergies.
 
According to the study, the package contains a booster that ignites anti-inflammatory response to the microscopic mites which, when amassed by the millions, could resemble dust and cause breathing difficulties even for those who aren't allergic.
 
Reported to exist in 84 percent of US households, dust mites inhabit mattresses, sofas and rugs, which offer them frequent access to human skin, triggering allergies and breathing problems.
 
Young asthmatics are particularly sensitive to dust mites and, according to guidelines from the American College of Allergy, Asthma & Immunology, 45 percent are allergic to them.
 
"This work suggests a way forward to alleviate mite-induced asthma in allergy sufferers," says contributing author Peter Thorne, a public health professor at UI.
 
The key ingredient in the booster has been successfully used in cancer vaccines and the study in question represents its first use in a dust mite allergy vaccine.
 
Called CpG, the adjuvant (booster) calls immune cells into action and, in turn, the activated immune cells imbibe it, thereby unleashing the vaccine carried by the CpG particles.
 
Upon reception of the vaccine, immune cells perform their anti-inflammatory duties and later dispose of the CpG particles.
 
"Our research explores a novel approach to treating mite allergy in which specially-encapsulated miniscule particles are administered with sequences of bacterial DNA that direct the immune system to suppress allergic immune responses," says Thorne.
 
The research team is currently at work on further testing of the vaccine in hopes that it will soon be available to those who suffer from dust mite allergies.
 
The study was published in American Association of Pharmaceutical Scientists (AAPS) Journal.
 

© AFP/Relaxnews 2014

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Wait Until October to Get Flu Shot: Expert

Sunday, 21 Sep 2014 09:57 AM

It's best to wait until October to get the flu shot, says a top infectious disease expert.

Otherwise, there  . . .

Blood Sugar Control Doesn't Help Diabetics Avoid Heart Attacks: Study

Saturday, 20 Sep 2014 09:06 AM

A six-year study of people with type 2 diabetes found that intensively lowering blood pressure had a long-lasting effect . . .

700 Babies Possibly Exposed to TB at Texas Hospital

Friday, 19 Sep 2014 23:45 PM

More than 700 infants may have been exposed to tuberculosis at an El Paso hospital over the past year by an employee rec . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved